Approval · Notice of Compliance 1424 · 2000
MIRAPEX: Notice of Compliance 1424
Issued February 8, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1424
- Date
- February 8, 2000
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antiparkinsonian agent/dopamine agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIRAPEX | 02241594 | Cancelled Post Market |
Medicinal ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE 0.5 MG per TAB